FDA Kicks off Reauthorization Process for PDUFA

Tuesday, May 12, 2015

Source: Regulatory Affairs Professionals Society

The US Food and Drug Administration (FDA) has announced the start of the next reauthorization process for the Prescription Drug User Fee Act (PDUFA), a major framework under which most new drug products in the US are reviewed.

View All News »